Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue July 2014
 •  Beiersdorf Opens Plant in Mexico  •  Fragrance Use Varies Around the World  •  Uncertainty About Energy Dogs US Chemical Sector  •  M.A.C Has a Maleficent Presence on Social Media  •  Greenpeace Activists Balk at Plea Deal
Print

Chattem Reports Results, Increases Fiscal 2007 Outlook



Published March 6, 2007
Related Searches: quarter growth anti brand
Post a comment
Chattem said sales rose 8% in fiscal 2006 to $300.5 million. Revenue growth for the fiscal year was led by brands such as Gold Bond, Selsun and the launch Icy Hot Pro-Therapy. The increase excludes the divested pHisoderm brand. Fourth quarter sales rose less than 2% to $65.1 million compared to $63.9 million in the prior year fourth quarter.

In early January, Chattem completed the acquisition of five brands from Johnson & Johnson—ACT anti-cavity mouthwash, Cortizone anti-itch product, Unisom OTC sleep-aid, Kaopectate anti-diarrhea product and Balmex diaper-rash product for $410 million.


blog comments powered by Disqus